TEDCO Invests in Higher Medicine
Source: External source
Higher Medicine is a company working to develop functional cures for Kabuki syndrome (KS) using epigenetic modifying molecules. The business aims to restore the open versus closed chromatin balance, the primary cause of KS, by using an LSD-1 inhibitor and accelerating into a patient clinical study.
Posted June 16, 2025
About TEDCO
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.
Media Contacts
Tammi Thomas, President, TEDCO, tthomas@tedcomd.com
Rachael Kalinyak, Associate Director, Marketing & Communications, TEDCO, rkalinyak@tedcomd.com